News

Siemens to acquire Dotmatics in $5.1 billion deal in Life Science portfolio push Siemens AG said on Wednesday it will acquire U.S.-based Dotmatics for $5.1 billion from private equity firm Insight ...
This was, of course, before US president Donald Trump’s address from the Rose Garden of the White House on April 2, in which ...
Costly investment programmes to facilitate Europe’s green energy transition are weakening the credit metrics of regulated gas ...
Jenbach-based engine maker INNIO Group is expanding its production capacity with a new site in Hall, Tyrol, Austria. Spanning ...
RBC Capital analyst Mark Fielding maintained a Hold rating on Siemens (0P6M – Research Report) today and set a price target of €215.00. The ...
Morgan Stanley analyst Max Yates lowered the firm’s price target on Siemens (SIEGY) to EUR 215 from EUR 250 and keeps an Overweight rating on ...
Deutsche Bank analyst Gael De-Bray maintained a Hold rating on Siemens ( 0P6M – Research Report) today and set a price target of €215.00. The company’s shares closed yesterday at €176.52. Filter, ...
Pharmaceutical Technology® spoke with Alexander Seyf, CEO and co-founder of Autolomous, about the use of artificial intelligence and machine learning in pharmaceutical development and manufacturing.
FDA has granted full approval to Bayer’s larotrectinib (brand name Vitrakvi), a first-in-class tropomyosin receptor kinase (TRK) inhibitor, for treatment of solid tumors in both adult and pediatric ...